Boundless Bio Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Boundless Bio stock have an average target of 23, with a low estimate of 20 and a high estimate of 25. The average target predicts an increase of 141.34% from the current stock price of 9.53.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$23	$24	$25
Change	+109.86%	+141.34%	+151.84%	+162.33%

Analyst Ratings

The average analyst rating for Boundless Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24	May '24
Strong Buy	2	2	2	2	1	1
Buy	1	1	1	1	2	2
Hold	2	2	2	2	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Cherny Leerink Partners	Leerink Partners	Buy Initiates $25	Buy	Initiates	$25	+162.33%	Apr 22, 2024
Yige Guo Guggenheim	Guggenheim	Strong Buy Initiates $24	Strong Buy	Initiates	$24	+151.84%	Apr 22, 2024
Joseph Catanzaro Piper Sandler	Piper Sandler	Buy Initiates $20	Buy	Initiates	$20	+109.86%	Apr 22, 2024
Mohit Bansal Citigroup	Citigroup	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Dec 10, 2018
Raju Prasad William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Nov 7, 2018

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.